Crystal structure, mutational analysis and RNA-dependent ATPase activity of the yeast DEAD-box pre-mRNA splicing

Agata Jacewicz1, Beate Schwer2, Paul Smith1

  • 1Molecular Biology Program, Sloan-Kettering Institute, New York, NY 10065, USA.

Nucleic Acids Research
|October 12, 2014
PubMed

Insights

Yeast Prp28, a splicing factor, has a catalytic domain with RNA-dependent ATPase activity. Key residues in ATP and RNA binding sites are essential for its function in pre-mRNA splicing.

Area of Science:

  • Molecular Biology
  • Biochemistry
  • Structural Biology

Background:

  • Yeast Prp28 is a DEAD-box protein crucial for pre-mRNA splicing.
  • It functions by displacing U1 small nuclear ribonucleoprotein (snRNP) from the 5' splice site.

Purpose of the Study:

  • To characterize the structure and function of Yeast Prp28.
  • To identify key residues and domains essential for its RNA-dependent ATPase activity and in vivo function.

Main Methods:

  • Protein expression and purification of recombinant Prp28 and its C-terminal domain.
  • Crystallography to determine the structure of Prp28-(127-588) bound to AMPPNP•Mg2+.
  • Alanine scanning mutagenesis to assess the in vivo importance of specific amino acid residues.
  • Analysis of dominant-negative growth defects caused by mutant Prp28 overexpression.

Main Results:

  • Yeast Prp28 consists of a N-terminal segment and a C-terminal catalytic domain with RNA-dependent ATPase activity.
  • The crystal structure of the catalytic domain revealed a conformation poised for ATP binding but not hydrolysis.
  • Specific residues in the ATP-binding (e.g., Asp341, Glu342) and RNA-binding sites (e.g., Arg476) are critical for Prp28 activity.
  • Synthetic lethality revealed functional redundancy in ATP- and RNA-binding sites.

Conclusions:

  • The structure and mutagenesis data elucidate the mechanism of Yeast Prp28 in pre-mRNA splicing.
  • Essential residues and functional redundancies within the ATP and RNA binding sites have been identified.
  • Defective ATP-site mutants exhibit dominant-negative effects, impacting cell growth.